
Roche has unveiled plans for its new main office building in Basel, Switzerland, that will accommodate more than 1,800 people …
Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …
Medical communications agency Medea Communications has landed a brief to prepare the ground for a new sedative from Finnish company …
Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …

Lung cancer is the most common cancer in the world, with 1.3 million new cases diagnosed every year. The vast …
Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …

The European Medicines Agency (EMEA) has admitted that the level of patient involvement in its activities is unsatisfactory.As a result …
Rebecca Lim has been appointed by WorldEvents to lead its new Hong Kong office. She is an event professional with …

UK patients could next year be given access to drugs that are still in the later stages of clinical development, …

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Pharmaceutical Development Services Ltd (PDS) has expanded its API (Active Pharmaceutical Ingredient) auditing capability, appointing two new associates. Paul Butler …

The US Senate has passed new healthcare legislation, giving President Barack Obama signs of progress on reform in both parliamentary …
Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …

The UK stands to lose one of its flagship pharmaceutical manufacturing facilities with the recent announcement that Sanofi-Aventis’ site in …
Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …

Roche has become the second pharma company to tackle sidewiki on its corporate website, posting an entry that sets out …
Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …

Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
The logistical challenges of transporting clinical trials samples over long distances arerapidly being overcome, says Sue Lee, Manager of Biopharm …